PD-L1 expression is usually analyzed by immunohistochemistry and scored using the CPS (Combined Positive Score), defined as the sum of PD-L1-positive cancer cells and monocytes/lymphocytes divided by the total number of tumor cells x 100 [5]. This evidence concerns the gene CD274 and neoplasm.